APARITO
Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5™ eCOA platform. The Atom5™ platform is Part 11, GDPR and HIPPA compliant and supports clinical trials at scale with video eCOAs, ePROs, Wearables, Telemedicine and eConsent in 193 countries and 125 languages to capture more frequent patient-generated data in the clinic and at home. This moves from relying on sterile, snapshot assessments during clinic visits to continuous, real-time, real-world data utilising novel eCOA and digital biomarkers.
APARITO
Industry:
Clinical Trials Health Care Medical
Founded:
2014-10-01
Address:
Wrexham, Wrexham, United Kingdom
Country:
United Kingdom
Website Url:
http://www.aparito.com
Total Employee:
11+
Status:
Active
Contact:
+44 1978 896 191
Email Addresses:
[email protected]
Total Funding:
1.02 M GBP
Technology used in webpage:
Domain Not Resolving Person Schema Gravatar Profiles
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Campus des Technologies de la Santé/CTS Healthcare
CTS Healthcare provides services to promote the growth and development of companies in the medical sector
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Hoth Intelligence
Seeing is everything. We use augmented reality to make healthcare better.
myTomorrows
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Perceiv AI
AI-driven precision medicine, forecasting disease progression
Phrase Health
Phrase Health is empowering teams with EHR data and collaborative tools that drive improved clinical outcomes.
CardioSignal
Cardiac monitoring via smartphone
Current Employees Featured
Founder
Investors List
Wealth Club
Wealth Club investment in Seed Round - Aparito
Bethnal Green Ventures
Bethnal Green Ventures investment in Seed Round - Aparito
Bayer
Bayer investment in Seed Round - Aparito
DigitalHealth.London Accelerator
DigitalHealth.London Accelerator investment in Seed Round - Aparito
MassChallenge
MassChallenge investment in Non Equity Assistance - Aparito
Bethnal Green Ventures
Bethnal Green Ventures investment in Pre Seed Round - Aparito
Official Site Inspections
http://www.aparito.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.34 K
- Host name: ec2-54-228-80-7.eu-west-1.compute.amazonaws.com
- IP address: 54.228.80.7
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Aparito"
About Aparito, a wholly owned subsidiary of Eli Lilly …
Aparito was founded by Dr. Elin Haf Davies in 2014 to empower patients in the drug development pathway and transform how clinical studies are conducted and novel eCOAs are developed. Initially designed for rare diseases, Aparito’s …See details»
Aparito - Crunchbase Company Profile & Funding
Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5â„¢ eCOA platform. The Atom5â„¢ platform is Part …See details»
Aparito - a wholly owned subsidiary of Eli Lilly and …
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials.See details»
Aparito Company Profile 2024: Valuation, Investors, Acquisition
Ascension (Venture Capital), Bayer, Bethnal Green Ventures, Better Society Capital, and Development Bank of Wales are 5 of 14 investors who have invested in Aparito. Who are …See details»
Welsh medtech venture Aparito acquired by US firm Eli …
Jul 11, 2024 Global pharmaceutical company Eli Lilly and Company has acquired Aparito, in a deal providing a multi-million-pound profitable exit for the Development Bank of Wales. The Wrexham-based medtech business was set …See details»
Eli Lilly acquires Aparito - 2024-07-11 - Crunchbase
Jul 11, 2024 Aparito Aparito digitise clinical trials and capture real-world data through our eCOA platform using video assessments, wearable devices and ePROs Acquiring Organization: Eli …See details»
Aparito - Leadership Team - The Org
The Leadership Team at Aparito, comprising the Chief Operations Officer, Chief Executive Officer, Chief Marketing Officer, and Chief Scientific Officer, drives strategic vision and operational …See details»
Aparito - Products, Competitors, Financials, Employees, …
Aparito. 's Products & Differentiators. Atom5TM. Atom5â„¢ is a highly-configurable disease and language-agnostic clinical trial platform that supports hybrid and decentralized clinical trials …See details»
Aparito - Crunchbase
Aparito focuses on digitizing clinical trials and capturing real-world data, while Coriell Life Sciences and myTomorrows connect patients with treatments. Phrase Health empowers …See details»
Aparito is now a wholly owned subsidiary of Eli Lilly and Company
+44 1978 896 191 11 Gwenfro Technology Park Croesnewydd Road Wrexham LL13 7YPSee details»
BGV Blog - 10 Questions with Aparito
Jun 25, 2021 Welcome to the first edition of our new blog series '10 Questions with…' where we sit down with founders from our portfolio to shed more light on their journeys of founding and …See details»
Aparito Partnership - TruLab
July 31 2023. Aparito and TruLab, two companies focused on improving rare disease studies, have formed a partnership to improve the efficiency and experience of clinical trials.. TruLab’s …See details»
Patient Group Accelerator - Aparito
Aparito launched the Accelerator programme in 2020 to provide an initiative where a company and patient community, with the support of patient advocacy groups, can collaborate as peers. …See details»
Aparito - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Non Equity Assistance - …See details»
Aparito and the Atom5â„¢ eCOA platform - YouTube
Aparito digitises what’s important to patients in clinical trials and captures real-world data through mobile apps, video assessments & wearable devices.Our ...See details»
Introducing Aparito - a company specialising in capturing patient ...
Sep 10, 2020 Aparito is a med-tech company specialising in capturing patient generated data and digital endpoints remotely, with a specific expertise in decentralised/ hy...See details»
Atom5â„¢ eCOA Platform - Aparito
Atom5â„¢ enables sponsors to monitor study patients in the clinic and at home using our eCOA platform’s video assessments, ePROs, telemedicine, wearable devices and eConsent …See details»
Clinical Portal - Aparito
The portal enables clinicians to upload clinical data to the system and communicate directly with individual patients. All patient captured data can be viewed by sponsors and/or CROs in real …See details»
Multi-Device Patient Data Capture - Aparito
Available on iOS and Android, the Atom5â„¢ smartphone app enables patients to engage with clinical trials on a familiar device.See details»